Metastatic Bronchioloalveolar Carcinoma and Metastatic Adenocarcinoma of the Lung: Comparison of Clinical Manifestations, Chemotherapeutic Responses, and Prognosis

EDWARD R. FELDMAN, ROBERT T. EAGAN, DANIEL J. SCHAID

Research output: Contribution to journalArticle

45 Scopus citations

Abstract

Between 1975 and 1985, 25 patients with metastatic bronchioloalveolar carcinoma and 223 patients with metastatic adenocarcinoma of the lung received experimental cisplatin-based chemotherapy at the Mayo Clinic. The chemotherapeutic response rates were 32% and 33%, respectively. The median times to progression of disease were identical (3 months in both groups). The median survival times were 4 months and 6 months, respectively. Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung.

Original languageEnglish (US)
Pages (from-to)27-32
Number of pages6
JournalMayo Clinic proceedings
Volume67
Issue number1
DOIs
StatePublished - Jan 1 1992

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Metastatic Bronchioloalveolar Carcinoma and Metastatic Adenocarcinoma of the Lung: Comparison of Clinical Manifestations, Chemotherapeutic Responses, and Prognosis'. Together they form a unique fingerprint.

  • Cite this